Osteoporosis treatment with zoledronic acid in pediatric population at a university hospital in Western Saudi Arabia: A 13-year experience

OBJECTIVES: To highlight the clinical benefit, efficacy, and safety of zoledronic acid (ZA) therapy in children and adolescents with primary and secondary osteoporosis. METHODS: This is a retrospective observational study of 131 children and adolescents visiting the Pediatric Endocrine Clinic at Kin...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Agha, Abdulmoein E., Hayatalhazmi, Rahaf S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Saudi Medical Journal 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673368/
https://www.ncbi.nlm.nih.gov/pubmed/26593164
http://dx.doi.org/10.15537/smj.2015.11.12590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673368/
https://www.ncbi.nlm.nih.gov/pubmed/26593164
http://dx.doi.org/10.15537/smj.2015.11.12590

Ejemplares similares